Clinical Trial Update: A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemotherapy for Metastatic Non-Small Cell Lung Cancer

View source ↗

Summary

This clinical trial update describes a first-line study in metastatic non-small cell lung cancer evaluating nivolumab plus ipilimumab with two cycles of chemoth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Carcinoma, Non-Small-Cell Lung | Status: ACTIVE_NOT_RECRUITING